Douglas B. Kell

63.3k total citations · 17 hit papers
560 papers, 40.6k citations indexed

About

Douglas B. Kell is a scholar working on Molecular Biology, Biomedical Engineering and Analytical Chemistry. According to data from OpenAlex, Douglas B. Kell has authored 560 papers receiving a total of 40.6k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Molecular Biology, 87 papers in Biomedical Engineering and 47 papers in Analytical Chemistry. Recurrent topics in Douglas B. Kell's work include Microbial Metabolic Engineering and Bioproduction (88 papers), Metabolomics and Mass Spectrometry Studies (75 papers) and Spectroscopy and Chemometric Analyses (46 papers). Douglas B. Kell is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (88 papers), Metabolomics and Mass Spectrometry Studies (75 papers) and Spectroscopy and Chemometric Analyses (46 papers). Douglas B. Kell collaborates with scholars based in United Kingdom, Denmark and South Africa. Douglas B. Kell's co-authors include Etheresia Pretorius, Royston Goodacre, David Broadhurst, Arseny S. Kaprelyants, Warwick B. Dunn, Stephen G. Oliver, Hazel M. Davey, Joshua Knowles, Jem J. Rowland and Pedro Mendes and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Douglas B. Kell

553 papers receiving 39.2k citations

Hit Papers

Procedures for large-scale metab... 1987 2026 2000 2013 2011 2004 2004 2001 1987 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
    2011 2.3k citations Warwick B. Dunn, David Broadhurst et al. profile →
  2. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression
    2004 960 citations Douglas B. Kell, Michael White et al. profile →
  3. Metabolomics by numbers: acquiring and understanding global metabolite data
    2004 909 citations Warwick B. Dunn, Douglas B. Kell et al. Trends in biotechnology profile →
  4. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations
    2001 769 citations David Broadhurst, Douglas B. Kell et al. profile →
  5. The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology
    1987 638 citations Douglas B. Kell et al. profile →
  6. Computational cluster validation in post-genomic data analysis
    2005 621 citations Joshua Knowles, Douglas B. Kell et al. Bioinformatics profile →
  7. Statistical strategies for avoiding false discoveries in metabolomics and related experiments
    2006 613 citations David Broadhurst, Douglas B. Kell profile →
  8. Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses
    1996 607 citations Douglas B. Kell et al. profile →
  9. Development of a Robust and Repeatable UPLC−MS Method for the Long-Term Metabolomic Study of Human Serum
    2009 540 citations Warwick B. Dunn, David Broadhurst et al. Analytical Chemistry profile →
  10. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation.
    1998 528 citations Douglas B. Kell et al. Bioinformatics profile →
  11. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
    2014 454 citations Douglas B. Kell, Etheresia Pretorius Metallomics profile →
  12. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
    2020 326 citations Douglas B. Kell, Etheresia Pretorius et al. profile →
  13. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
    2021 316 citations Etheresia Pretorius, Maré Vlok et al. Cardiovascular Diabetology profile →
  14. Breeding crop plants with deep roots: their role in sustainable carbon, nutrient and water sequestration
    2011 315 citations Douglas B. Kell profile →
  15. The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation
    2022 185 citations Martin Pagé, Douglas B. Kell et al. profile →
  16. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
    2022 144 citations Etheresia Pretorius, Chantelle Venter et al. Cardiovascular Diabetology profile →
  17. Long COVID: pathophysiological factors and abnormalities of coagulation
    2023 127 citations Douglas B. Kell, Etheresia Pretorius et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas B. Kell United Kingdom 99 22.1k 5.6k 3.5k 2.6k 2.5k 560 40.6k
Berk Hess Sweden 42 45.1k 2.0× 9.2k 1.6× 6.2k 1.8× 927 0.4× 2.6k 1.0× 119 83.5k
Andrew Dalke United States 9 26.7k 1.2× 5.9k 1.1× 3.6k 1.0× 597 0.2× 1.8k 0.7× 13 56.0k
David van der Spoel Sweden 57 31.8k 1.4× 7.3k 1.3× 5.5k 1.5× 761 0.3× 1.6k 0.6× 168 61.7k
Erik Lindahl Sweden 54 40.9k 1.9× 7.5k 1.3× 4.7k 1.3× 696 0.3× 2.3k 0.9× 197 71.6k
John C. Lindon United Kingdom 90 26.0k 1.2× 3.7k 0.7× 7.4k 2.1× 2.7k 1.1× 1.3k 0.5× 444 35.5k
Royston Goodacre United Kingdom 89 16.6k 0.8× 7.4k 1.3× 4.0k 1.1× 5.3k 2.1× 3.3k 1.3× 464 30.7k
William Humphrey United States 21 24.5k 1.1× 5.9k 1.0× 3.6k 1.0× 595 0.2× 1.4k 0.6× 39 53.5k
Jeremy C. Smith United States 92 32.0k 1.4× 5.5k 1.0× 3.7k 1.1× 453 0.2× 2.4k 0.9× 848 58.8k
Tom Darden United States 28 33.8k 1.5× 5.5k 1.0× 4.3k 1.2× 455 0.2× 1.7k 0.7× 49 55.7k
Elaine Holmes United Kingdom 115 40.8k 1.9× 4.5k 0.8× 7.1k 2.0× 3.1k 1.2× 2.1k 0.8× 546 56.8k

Countries citing papers authored by Douglas B. Kell

Since Specialization
Citations

This map shows the geographic impact of Douglas B. Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas B. Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas B. Kell more than expected).

Fields of papers citing papers by Douglas B. Kell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas B. Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas B. Kell. The network helps show where Douglas B. Kell may publish in the future.

Co-authorship network of co-authors of Douglas B. Kell

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas B. Kell. A scholar is included among the top collaborators of Douglas B. Kell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas B. Kell. Douglas B. Kell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kell, Douglas B., Gregory Y.H. Lip, & Etheresia Pretorius. (2024). Fibrinaloid Microclots and Atrial Fibrillation. Biomedicines. 12(4). 891–891. 4 indexed citations
2.
Venter, Chantelle, Maré Vlok, Malebogo Ngoepe, et al.. (2021). SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Bioscience Reports. 41(8). 121 indexed citations
3.
4.
5.
Pretorius, Etheresia, Chantelle Venter, Gert Jacobus Laubscher, et al.. (2020). Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report. Cardiovascular Diabetology. 19(1). 193–193. 46 indexed citations
6.
Thampy, Harish, et al.. (2019). Very rapid flow cytometric assessment of antimicrobial susceptibility during the apparent lag phase of microbial (re)growth. Microbiology. 165(4). 439–454. 12 indexed citations
7.
Swainston, Neil, Mark S. Dunstan, Adrian J. Jervis, et al.. (2018). PartsGenie: an integrated tool for optimizing and sharing synthetic biology parts. Bioinformatics. 34(13). 2327–2329. 22 indexed citations
8.
Carbonell, Pablo, Jerry Wong, Neil Swainston, et al.. (2018). Selenzyme: enzyme selection tool for pathway design. Bioinformatics. 34(12). 2153–2154. 69 indexed citations
9.
Pretorius, Etheresia, et al.. (2018). Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains . Journal of The Royal Society Interface. 15(139). 20170941–20170941. 45 indexed citations
10.
Kell, Douglas B. & Louise C. Kenny. (2016). A Dormant Microbial Component in the Development of Preeclampsia. Frontiers in Medicine. 3. 60–60. 67 indexed citations
11.
Kell, Douglas B. & Etheresia Pretorius. (2014). Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 6(4). 748–773. 454 indexed citations breakdown →
12.
Patel, Yogendra, Catherine A. Heyward, Michael White, & Douglas B. Kell. (2011). Predicting the points of interaction of small molecules in the NF-κB pathway. BMC Systems Biology. 5(1). 32–32. 1 indexed citations
13.
Flavell, R. B., C. H. Brito Cruz, Mike Christie, et al.. (2011). Moving forward with biofuels.. Nature. 474(7352). 2 indexed citations
14.
Dunn, Warwick B., David Broadhurst, Sue Francis‐McIntyre, et al.. (2009). Development of a Robust and Repeatable UPLC−MS Method for the Long-Term Metabolomic Study of Human Serum. Analytical Chemistry. 81(4). 1357–1364. 540 indexed citations breakdown →
15.
Kell, Douglas B., et al.. (2008). Molecular Structure Elucidation Using Ant Colony Optimization. 1 indexed citations
16.
Smallbone, Kieran, Evangelos Simeonidis, David S. Broomhead, & Douglas B. Kell. (2007). Something from nothing − bridging the gap between constraint‐based and kinetic modelling. FEBS Journal. 274(21). 5576–5585. 77 indexed citations
17.
Kell, Douglas B. & Ross D. King. (2000). On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: the need for machine learning. Trends in biotechnology. 18(3). 93–98. 62 indexed citations
18.
Kell, Douglas B., et al.. (2000). Resuscitating a logical approach to viability in the face of an "eastern wind". 2 indexed citations
19.
Woodward, Andrew M., et al.. (1994). Nonlinear dielectric properties and their relationship to the physiological state(resting or active)of Saccharomyces cerevisiae. Osaka City University (Osaka City University). 35. 53–58. 2 indexed citations
20.
Kell, Douglas B., et al.. (1981). Polarographic Assay of the Binding of Certain “Probe” Molecules to Illuminated Bacteriorhodopsin Sheets. Photobiochemistry and photobiophysics.. 2(1-2). 105–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berk Hess Breakdown of academic impact, for papers by Andrew Dalke Breakdown of academic impact, for papers by David van der Spoel Breakdown of academic impact, for papers by Erik Lindahl Breakdown of academic impact, for papers by John C. Lindon Breakdown of academic impact, for papers by Royston Goodacre Breakdown of academic impact, for papers by William Humphrey Breakdown of academic impact, for papers by Jeremy C. Smith Breakdown of academic impact, for papers by Tom Darden Breakdown of academic impact, for papers by Elaine Holmes
Rankless by CCL
2026